Pharmainstru Elec Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -79.88%
(FY 2019)
- Profit 12.45%
(FY 2019)
- Ebitda 8.16%
(FY 2019)
- Net Worth 32.68%
(FY 2019)
- Total Assets 17.69%
(FY 2019)
About Pharmainstru Elec
The Company is engaged in the Energy And Power Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhanashri Kolte, Ashish Kolte, Pankaj Kolte, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC246797
- Company No.
246797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pharmainstru Elec Private Limited offer?
Pharmainstru Elec Private Limited offers a wide range of products and services, including Turnkey Projects, Turnkey Electrical Projects, Electric Control Panel, Electrical Panels, AMF Panels, VFD, PLC, HMI & Control Equipments, Servo Drives, Motor Drives, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Pharmainstru Elec?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhanashri Kolte  | Director | 08-Aug-2013 | Current |
| Ashish Kolte | Director | 08-Aug-2013 | Current |
| Pankaj Kolte | Director | 08-Aug-2013 | Current |
| Devendra Kolte | Director | 08-Aug-2013 | Current |
| Rupali Kolte | Director | 08-Aug-2013 | Current |
Financial Performance of Pharmainstru Elec.
Pharmainstru Elec Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 79.88% decrease. The company also saw a substantial improvement in profitability, with a 12.45% increase in profit. The company's net worth Soared by an impressive increase of 32.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmainstru Elec?
In 2019, Pharmainstru Elec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmainstru Elec?
Pharmainstru Elec has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmainstru Elec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmainstru Elec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
